Corporate ActionJun 1, 2026, 05:05 PM
China SXT Pharma to Offer Up to $100M Class A Shares via ATM
AI Summary
China SXT Pharmaceuticals, Inc. entered into a sales agreement with Univest Securities, LLC on June 1, 2026, to offer and sell up to $100,000,000 of its Class A ordinary shares through an at-the-market offering. Univest Securities will act as the sales agent, earning a 3.00% commission on gross proceeds, plus a $0.003 per share trading and exchange fee reimbursement. The offering is registered under the company's existing shelf registration statement.
Key Highlights
- China SXT Pharmaceuticals entered a sales agreement for an at-the-market offering.
- The company will offer up to $100,000,000 in Class A ordinary shares.
- Univest Securities, LLC will serve as the sales agent.
- The sales agent's commission is 3.00% of the gross proceeds.
- The company will reimburse $0.003 per share for trading and exchange fees.
- The offering is registered under a Form F-3 shelf registration statement.
Price Impact
More from SXTC